Ferreira, N., Agorku, D., Rosa, A., Roosz, J., Christ, L., Anderle, N., … Ramos-Gomes, F. (2026). Advanced Human Immune Cell-Organoid Co-Cultures for Functional Testing of Cancer Nanovaccines. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 13(10), e15199. https://doi.org/10.1002/advs.202515199 (Original work published 2026)
Immunotherapy
Besançon, A., Baas, M., Goncalves, T., Valette, F., Waldmann, H., Chatenoud, L., & You, S. (2017). The Induction and Maintenance of Transplant Tolerance Engages Both Regulatory and Anergic CD4+ T cells. Frontiers in Immunology, 8, 218. https://doi.org/10.3389/fimmu.2017.00218 (Original work published 2017)
Kuhn, C., Rezende, R., da Cunha, A., Valette, F., Quintana, F., Chatenoud, L., & Weiner, H. (2017). Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain. Journal of Autoimmunity, 76, 115-122. https://doi.org/10.1016/j.jaut.2016.10.001 (Original work published 2017)
Ostrov, D., Alkanani, A., McDaniel, K., Case, S., Baschal, E., Pyle, L., … Michels, A. (2018). Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. The Journal of Clinical Investigation, 128(5), 1888-1902. https://doi.org/10.1172/JCI97739 (Original work published 2018)
Arif, S., Gomez-Tourino, I., Kamra, Y., Pujol-Autonell, I., Hanton, E., Tree, T., … Peakman, M. (2020). GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells. Diabetologia, 63(6), 1186-1198. https://doi.org/10.1007/s00125-020-05130-7 (Original work published 2020)
Weng, S., Zhang, J., Ma, H., Zhou, J., Jia, L., Wan, Y., … Xu, Y. (2022). B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent Mycobacterium tuberculosis infection. Frontiers in Immunology, 13, 1025931. https://doi.org/10.3389/fimmu.2022.1025931 (Original work published 2022)
Pancisi, E., Granato, A., Scarpi, E., Ridolfi, L., Carloni, S., Moretti, C., … Petrini, M. (2022). Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center. Vaccines, 10(7), 999. https://doi.org/10.3390/vaccines10070999 (Original work published 2022)
Chen, C.-H., Weng, T.-H., Huang, H.-H., Huang, L.-Y., Huang, K.-Y., Chen, P.-R., … Liao, K.-W. (2023). A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy. Journal of Experimental & Clinical Cancer Research : CR, 42(1), 29. https://doi.org/10.1186/s13046-023-02601-8 (Original work published 2023)
Foppen, M., Rohaan, M., Borgers, J., Philips, D., Vyth-Dreese, F., Beijnen, J., … Haanen, J. (2024). Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial. Oncology Research and Treatment, 47(7-8), 351-359. https://doi.org/10.1159/000537896 (Original work published 2024)
Benne, N., Braake, D., Porenta, D., Lau, C., Mastrobattista, E., & Broere, F. (2024). Autoantigen-Dexamethasone Conjugate-Loaded Liposomes Halt Arthritis Development in Mice. Advanced Healthcare Materials, 13(12), e2304238. https://doi.org/10.1002/adhm.202304238 (Original work published 2024)